← Retour à la une
États-Unis · Plateformes & données · MarketBeat

Kura Oncology Q3 Earnings Call Highlights

Publié par MarketBeat · États-Unis il y a 1 h
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Kura Oncology (NASDAQ:KURA) reported third-quarter 2026 net product revenue of $13.9 million for leukemia treatment KOMZIFTI, up 53% from the prior quarter, as the company expanded prescribing accounts and prepared clinical data on combinations with other therapies. Management also said it had reac

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

À lire aussi

MarketWatch

One reason Children’s Place is filing for bankruptcy? Not enough children.

 Seeking Alpha

Petrobras profit misses estimates as spending rises, payouts disappoint

 The Motley Fool

3 Magnificent Dividend Stocks Yielding 4% or More to Buy in November

 Investing.com

Five US states join FTC suit against Hims & Hers over privacy practices

 CNBC

Fed Governor Waller sees December hike likely, opens door to possible half-point increase

 TheStreet

This Simple Salt Swap Could Save 3 Million Lives a Year